Credit Agricole’s Standard BioTools LAB Stock Holding History

Credit Agricole’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-3,713	Closed	-$91K	–	1600
2014 Q3	$91K	Sell	3,713 -760	-17%	-$21.4K	﹤0.01%	1466
2014 Q2	$132K	Buy	+4,473	New	+$143K	﹤0.01%	1439

Other funds holding LAB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Agricole's LAB Position: Q4 2014 in Review

Credit Agricole sold out of Standard BioTools (LAB) in Q4 2014, closing a stake of 3,713 shares — an estimated $91K sold.

Credit Agricole first reported a position in LAB in Q2 2014 and held it in 2 quarters. The position peaked at $132K in Q2 2014. 100 funds tracked by Wall St. Rank hold LAB as of Q4 2014.

Credit Agricole reported no remaining Standard BioTools position as of Q4 2014 after selling out during the quarter.
Credit Agricole sold 3,713 Standard BioTools shares in Q4 2014, an estimated $91K.
Credit Agricole first reported a position in Standard BioTools in Q2 2014 and held it in 2 quarters.
Credit Agricole's Standard BioTools position peaked at $132K in Q2 2014.
100 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2014.

Based on Credit Agricole's 13F filing for Q4 2014, filed 9 Feb 2015.